## ICE: Intercontinental Exchange Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 1.4% below STRENGTH zone (3.0-6.0%); PEG 2.18 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($155.00)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Deutsche Bank Adjusts Price Target on Intercontinental Exchange to $167 From $165, Maintains Hold Rating**
- Source: marketscreener.com | 20251217T142333 | Somewhat-Bullish | Relevance: 100%
- Deutsche Bank has increased its price target for Intercontinental Exchange (ICE) to $167 from $165, while maintaining a Hold rating on the stock. This adjustment comes amidst various market activities concerning ICE, including recent IPOs on its exchange and new product launches. The company operates regulated futures exchanges and OTC markets for various commodities and financial products globally.

**2. Intercontinental Exchange (NYSE:ICE) SVP Sells 1,600 Shares**
- Source: MarketBeat | 20251216T225639 | Somewhat-Bullish | Relevance: 100%
- Intercontinental Exchange (NYSE:ICE) Senior Vice President Douglas Foley sold 1,600 shares of company stock for a total of $261,120 on December 12th, reducing his holdings by 6.20%. Despite this insider sale, the company reported strong quarterly earnings with revenue exceeding expectations and analyst sentiment remains largely positive with a consensus "Buy" rating.

**3. Intercontinental Exchange : NYSE to Commence Delisting Proceedings with Respect to Warrants of Vicarious Surgical Inc. (RBOT WS)**
- Source: marketscreener.com | 20251216T210958 | Neutral | Relevance: 93%
- The NYSE announced it will commence delisting proceedings for the warrants of Vicarious Surgical Inc. (RBOT WS) due to "abnormally low selling price" levels. Trading in RBOT WS warrants will be immediately suspended, though trading in the company's Class A common stock (RBOT) will continue. Vicarious Surgical Inc. has the right to appeal this decision.

**4. NYSE Content Advisory: Pre-Market Update + AAF Advertising Hall of Fame to Ring NYSE Closing Bell**
- Source: Finviz | 20251216T140912 | Neutral | Relevance: 74%
- The New York Stock Exchange (NYSE) released a content advisory detailing its pre-market update and upcoming bell ceremonies for December 16, 2025. Kristen Scholer delivered the pre-market update, covering the November jobs report and a new partnership between Ticker Take and NYSE. The American Advertising Federation is set to ring the Closing Bell to celebrate its 75th anniversary, while Harbor Capital celebrated four of its ETFs by ringing the Opening Bell.

**5. Is S&P Global Still Attractive Near $500 After Years of Strong Share Price Gains**
- Source: Simply Wall Street | 20251217T073613 | Neutral | Relevance: 65%
- S&P Global's stock has seen strong gains but is currently considered overvalued based on two valuation approaches. The Excess Returns model suggests the stock is 57.9% overvalued, with an intrinsic value of $316.55 per share. The Price vs. Earnings (PE) ratio also indicates overvaluation, trading at 35.9x earnings compared to a Fair Ratio of 17.8x.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 5 ($18.72M) |
| Sells | 7 ($15.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.1%)
- Blackrock Inc.: 9.0% (+0.4%)
- State Street Corpora: 4.3% (+0.8%)
- JPMORGAN CHASE & CO: 3.0% (+109.5%)
- Morgan Stanley: 2.8% (-7.8%)

### Key Risks

1. Heavy insider selling: $15M sold (7 transactions in 90 days).
2. Long-term trend broken: trading 5.6% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.18 elevated, pricing in significant growth expectations. Forward P/E 21.3x stretched relative to 9% growth. Quality metrics strong (margin 32%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $91.6B |
| Beta | 1.05 |
| 52W Range | $142.29 - $189.35 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.18 |
| Forward P/E | 21.3 |
| Current P/E | 23.1 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.0% to 1.4% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.6pp (needs >3.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.94x), long-term trend not supportive. RSI neutral at 56. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.38% (CS: 56) | Neutral |
| RSI_14 | 56.1 | Neutral |
| MACD Histogram | 0.30 | Bullish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 0.944x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $160.06
- **Stop Loss:** $155.00 (3.2% risk)
- **Target:** $165.12 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 140
- **Position Value:** $22,408.40
- **Portfolio %:** 22.41%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-05 (Est: $1.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.61 | $1.71 | +6.4% |
| 2025Q2 | $1.77 | $1.81 | +2.3% |
| 2025Q1 | $1.70 | $1.72 | +1.0% |
| 2024Q4 | $1.49 | $1.52 | +2.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*